Dr. Nathaniel Park is a Research Staff Member at IBM Research-Almaden. His primary research interests are focused the development of new therapeutic materials, macromolecular diagnostic systems, and high-performance polymers. The preparation of these materials stems from new advances in controlled polymer synthesis and post-synthesis functionalization, enabling precise control over pendant functional groups, polymer architechture, and self-assembly properties.
Dr. Park completed his undergraduate studies at Montana State University, where he conducted research on the stereoselective synthesis of glycosyl ureas in the lab of Professor Hien Nguyen. Following graduation, he joined the lab of the late Professor David Gin at Memorial Sloan-Kettering Cancer Center in New York City, where he worked on the total synthesis of alkaloid natural products. He completed his graduate work at MIT in the lab of Professor Stephen Buchwald, where he developed new transition metal catalysts and continuous flow processes for C–N and C–F bond formation. After graduating from MIT in 2015, he joined IBM Research-Almaden where he completed postdoctoral work with Dr. James Hedrick. In 2017, he became a full-time Research Staff Member.